Study Overview
Sex: All
Age: 18 Years and older (Adult, Older Adult)
Accepts Healthy Volunteers? yes
No Study Documents
Study Overview
Sex: All
Age: 18 Years and older (Adult, Older Adult)
Accepts Healthy Volunteers? yes
No Study Documents
BGB-A317-305 JapicCTI-194799
Active, not recruiting
Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma
Beigene Study ID
BGB-A317-305 JapicCTI-194799
ClinicalTrials.gov ID
EudraCT Number
2018-000312-24
Clinical Drug Trials ID
CTR20181841
Sex: All
Age: 18 Years and older (Adult, Older Adult)
Accepts Healthy Volunteers? yes
No Study Documents
Sex: All
Age: 18 Years and older (Adult, Older Adult)
Accepts Healthy Volunteers? yes
No Study Documents